ElaineMMajerusMDPhD
Hematology • Saint Louis, MOClotting Disorder, Hemophilia & Bleeding Disorder
Professor, Internal Medicine, Washington University School of Medicine
Dr. Majerus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Barnes Jewish Hospital Plz
# Div
Saint Louis, MO 63110Phone+1 314-362-7216Fax+1 314-362-8813
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2000 - 2003- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1998 - 2000
Saint Louis University School of MedicineClass of 1998
Certifications & Licensure
IL State Medical License 2020 - 2026
MO State Medical License 1999 - 2025
Clinical Trials
- A Phase II Trial of Regadenoson in Sickle Cell Anemia Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- 3 citationsValoctocogene roxaparvovec gene transfer in participants with HIV.Margaret V Ragni, Elaine Majerus, Sylvia Fong, Bridget Yates, Stephen Scheeler
Blood Advances. 2023-04-25 - Erratum: Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease (Blood Advances (2017) 1:20 (1645-1649) DOI: 10.11...Joshua J. Field, Elaine M. Majerus, Victor R. Gordeuk
Blood Advances. 2017-10-24 - 31 citationsRandomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell diseaseJoshua J. Field, Elaine M. Majerus, Victor R. Gordeuk, Michel Gowhari, Carolyn Hoppe
Blood Advances. 2017-09-12
Press Mentions
Dr. Philip Majerus, Among the First to Discern Aspirin’s Heart Benefits, Dies at 79June 14th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
